(NASDAQ: CBLL) Ceribell's forecast annual revenue growth rate of 20.86% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.11%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.58%.
Ceribell's revenue in 2025 is $82,813,000.On average, 10 Wall Street analysts forecast CBLL's revenue for 2025 to be $3,336,386,359, with the lowest CBLL revenue forecast at $3,194,421,153, and the highest CBLL revenue forecast at $3,447,116,993. On average, 10 Wall Street analysts forecast CBLL's revenue for 2026 to be $4,266,375,307, with the lowest CBLL revenue forecast at $3,980,738,494, and the highest CBLL revenue forecast at $4,444,434,619.
In 2027, CBLL is forecast to generate $5,473,098,103 in revenue, with the lowest revenue forecast at $5,134,043,496 and the highest revenue forecast at $5,762,444,485.